Accessibility Menu
Pressure BioSciences logo

Pressure BioSciences

(OTC) PBIO

Current Price$0.00
Market Cap$49.20K
Since IPO (1996)-100%
5 Year-100%
1 Year+140%
1 Month-76%

Pressure BioSciences Financials at a Glance

Market Cap

$49.20K

Revenue (TTM)

$1.50M

Net Income (TTM)

-$31.36M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

3.99 (High)

Price

$0.00

Volume

2,426

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.20

Estimated Earnings Date

Aug 25, 2026

PBIO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pressure BioSciences

Industry

Life Sciences Tools and Services

Employees

16

CEO

Richard T. Schumacher

Headquarters

Canton, MA 02375, US

PBIO Financials

Key Financial Metrics (TTM)

Gross Margin

40%

Operating Margin

-5%

Net Income Margin

-15%

Return on Equity

0%

Return on Capital

29%

Return on Assets

-28%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$49.20K

Shares Outstanding

40.97M

Volume

2.43K

Avg. Volume

5.33K

Financials (TTM)

Gross Profit

$799.56K

Operating Income

-$9.50M

EBITDA

-$9.39M

Operating Cash Flow

-$3.19M

Capital Expenditure

-$7.50K

Free Cash Flow

-$3.19M

Cash & ST Invst.

$81.28K

Total Debt

$22.89M

Pressure BioSciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$421.79K

-17.6%

Gross Profit

$44.25K

-82.7%

Gross Margin

10.49%

N/A

Market Cap

$49.20K

N/A

Market Cap/Employee

$3.28K

N/A

Employees

15

N/A

Net Income

-$7.12M

-2.8%

EBITDA

-$3.49M

-249.6%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$14.25K

-42.9%

Total Debt

$29.19M

+50.4%

Accounts Receivable

$183.98K

-2.7%

Inventory

$541.93K

-2.1%

Long Term Debt

$519.32K

+112.8%

Short Term Debt

$28.67M

+49.6%

Return on Assets

-27.93%

N/A

Return on Invested Capital

29.22%

N/A

Free Cash Flow

-$705.91K

+21.5%

Operating Cash Flow

-$705.91K

+21.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MSIUMedical Supply International USA, Inc.
$0.00+0.00%
JWCAFJames E. Wagner Cultivation Corporation
$0.00+0.00%
IONMAssure Holdings Corp.
$0.00+400.00%
SZLSFStageZero Life Sciences Ltd.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%
SMCISuper Micro Computer
$30.46-0.05%

Questions About PBIO

What is the current price of Pressure BioSciences?

Pressure BioSciences is trading at $0.00 per share.

What is the 52-week range for Pressure BioSciences?

Over the past 52 weeks, Pressure BioSciences has traded between $0.00 and $0.20.

How much debt does Pressure BioSciences have?

As of the most recent reporting period, Pressure BioSciences reported total debt of $29.19M.

How much cash does Pressure BioSciences have on hand?

Pressure BioSciences reported $14.25K in cash and cash equivalents in its most recent financial results.

What is Pressure BioSciences’s dividend yield?

Pressure BioSciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.